Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Ci thin np nhn 15.4%
NEJM, 2023
Retatrutide is an investigational triple hormone agonist (GLP-1, GIP, glucagon) showing promising early results for obesity and type 2 diabetes, while tirzepatide is an FDA-approved dual agonist (GLP-1, GIP) available for use today
Alexandra Sowa who has helped countless GLP-1 patients reach their goals to help you get enough protein conveniently, quickly, and comfortably (AKA without digestive upset!)
$147 (6-mo) $149 (3-mo) $165 (monthly)
US$ 25.40
US$ 29.03
US$ 26.31
US$ 26.38
US$ 27.93
US$ 20.15
US$ 24.96
US$ 27.24
